FdaApplication

NDA 201110

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFERRING PHARMACEUTICALS INC
application_typeNDA
approval_date2020-04-29

Products (1)

ProductActive ingredientStrengthDosage form
MILPROSAPROGESTERONE1.78GMSYSTEM;VAGINAL

1 product